β-chemokine receptor expression in idiopathic inflammatory myopathies

Muscle and Nerve

Volumn 31, Issue 5, 2005, Pages 621-627

  De Paepe, Boel ^a   De Bleecker, Jan L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chemokines; Idiopathic inflammatory myopathy; Immunoblotting; Immunofluorescence; Inflammation

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID;

ARTICLE; BLOOD VESSEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; MUSCLE CELL; MUSCLE REGENERATION; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

BLOOD VESSELS; BLOTTING, WESTERN; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MUSCLE, SKELETAL; MYOSITIS; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 17744376790     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20294     Document Type: Article

References (28)

1. Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002;13:754-758.
2. Bartoli C, Civatte M, Pellissier JF, Figarella-Branger D. CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol 2001;102:385-392.
3. Buri C, Korner M, Scharli P, Cefai D, Uguccioni M, Mueller C, et al. CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease. Blood 2001;97:1543-1548.
4. Confalonieri P, Bernasconi P, Megna P, Galbiati S, Cornelio F, Mantegazza R. Increased expression of b-chemokines in muscle of patients with inflammatory myopathies. J Neuropathol Exp Neurol 2000;59:164-169.
5. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-982.
6. De Bleecker JL, Engel AG. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994;53:369-376.
7. De Bleecker JL, Engel AG. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 1995;146:1178-1187.
8. De Bleecker JL, De Paepe B, Vanwalleghem IE, Schröder JM. Differential expression of chemokines in inflammatory myopathies. Neurology 2002;58:1779-1785.
9. De Paepe B, Schröder JM, Martin JJ, Racz GZ, De Bleecker JL. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies. Neuromuscul Disord 2004;14:265-273.
10. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-115.
11. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997;186:131-137.
12. Gröne HJ, Weber C, Weber KS, Gröne EF, Rabelink T, Klier CM, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999;13:1371-1383.
13. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, et al. Overexpression of eotaxin and the CCR3 receptor in human artherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000;102:2185-2189.
14. Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001;44:1022-1032.
15. Kunkel SL, Strieter RM, Lindley IJ, Westwick J. Chemokines: new ligands, receptors, and activities. Immunol Today 1995;16:559-561.
16. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 1997;94:12053-12058.
17. Liprandi A, Bartoli C, Figarella-Branger D, Pellisier JF, Lepidi H. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol 1999;97:642-648.
18. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997;185:1371-1380.
19. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997;57:117-120.
20. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signalling. J Immunol 1999;162:3840-3850.
21. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
22. Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 2000;108:192-200.
23. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999;103:807-815.
24. Tanaka S, Green SR, Quehenberger O. Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes. Biochem Biophys Res Commun 2002;290:73-80.
25. Targoff IN, Miller FW, Medsger TA Jr, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997;9:527-535.
26. Topham PS, Csizmadia V, Soler D, Hines D, Gerald CJ, Salant DJ, et al. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest 1999;104:1549-1557.
27. Weber KSC, Nelson PJ, Grone HJ, Weber C. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 1999;19:2085-2093.
28. Wong LM, Myers SJ, Tsou CL, Gosling J, Arai H, Charo IF. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem 1997;272:1038-1045.